George Mosch
Family Medicine · Clearfield, PANPI 1265471023
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Novo Nordisk at 27.5% of the total. Reporting peaked in 2021 at $1,023 and has fallen 60.2% since, to $407 in 2023.
Across 173 payments — averaging $14.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$696
- AbbVie$462
- Pfizer$360
- Lilly USA, LLC$192
- AstraZeneca$109
- Johnson & Johnson$90
- plus $623 from 21 others
What the payments were for
- Food & beverage$2,533100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 49 | $696 |
| AbbVie(2 entities) | 31 | $462 |
| Pfizer | 28 | $360 |
| Lilly USA, LLC | 14 | $192 |
| AstraZeneca | 8 | $109 |
| Johnson & Johnson | 5 | $90 |
| GSK | 6 | $88 |
| Biohaven Pharmaceuticals, Inc. | 4 | $73 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Boston Scientific | 2 | $44 |
| Amarin Pharma, Inc. | 2 | $44 |
| Merck | 3 | $41 |
| Sunovion Pharmaceuticals Inc. | 2 | $32 |
| Amgen | 2 | $29 |
| Boehringer Ingelheim | 2 | $28 |
| Astellas Pharma US Inc | 2 | $27 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Nestle Healthcare Nutrition Inc. | 1 | $22 |
| Abbott | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Novartis | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
| Biogen | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Medtronic | 1 | $11 |
How this compares
$2,533 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 40 | $39,684 |
| JardianceEmpagliflozin | 19 | $20,452 |
| Atorvastatin Calcium | 91 | $1,447 |
| SynthroidLevothyroxine Sodium | 16 | $1,235 |
| Levothyroxine Sodium | 71 | $1,095 |
| Rosuvastatin Calcium | 35 | $956 |
| Omeprazole | 36 | $905 |
| Tamsulosin Hcl | 22 | $889 |
| Metoprolol Succinate | 47 | $862 |
| Lisinopril | 73 | $682 |
| Pantoprazole Sodium | 27 | $648 |
| Gabapentin | 27 | $624 |
| Losartan Potassium | 44 | $624 |
| ClopidogrelClopidogrel Bisulfate | 15 | $455 |
| Potassium Chloride | 17 | $408 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $360 | $39,68440 claims |
| Boehringer IngelheimJardiance | $28 | $20,45219 claims |
| AbbVieSynthroid | $462 | $1,23516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Clearfield
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.